Clinical Obesity, published by WILEY, is a leading journal in the field of Endocrinology, Diabetes, and Metabolism that strives to advance the understanding of obesity-related health issues. With an ISSN of 1758-8103 and an E-ISSN of 1758-8111, this journal provides a platform for cutting-edge research and findings pertaining to the epidemiology, pathophysiology, prevention, and treatment of obesity. Recognized with a Q2 ranking in both Endocrinology, Diabetes and Metabolism and Medicine (miscellaneous) categories, and boasting a Scopus rank of #90 out of 244, Clinical Obesity encompasses innovative studies that influence clinical practice and public health policies. While this journal operates under a subscription model, its discipline-specific contributions are invaluable for researchers, healthcare professionals, and students keen on addressing the complexities of obesity in a comprehensive manner.

Welcome to the Journal of Evidence-Based Dental Practice, a premier resource for cutting-edge research in the field of dentistry, published by Elsevier Inc. With an impressive impact factor and recognition as a Q1 journal in the miscellaneous category of dentistry for 2023, this journal serves as a critical platform for disseminating high-quality, evidence-based studies that influence practice and policy in dental care. Since its inception in 2001, it has provided valuable insights that rank it among the top 15% of journals in the general dentistry category, making it a crucial reference for researchers, professionals, and students dedicated to advancing dental science and patient care. Accessing the wealth of knowledge within its pages allows practitioners and scholars to stay informed about the latest advancements and methodologies in evidence-based dental practice. Your engagement with this journal helps foster a deeper understanding of best practices and innovative solutions in dentistry.

Complementary Therapies in Clinical Practice is a premier academic journal published by Elsevier Science Ltd, dedicated to advancing the field of complementary and alternative medicine. With an impressive impact factor placing it in the Q1 category for its field and a Scopus rank of 16 out of 105, it serves as a vital platform for sharing high-quality research and clinical insights. Established in 2005 and continuing through 2024, the journal is committed to disseminating evidence-based practices that enhance patient care and safety. Although it does not offer open access, the journal remains integral to researchers, clinicians, and students striving to integrate complementary therapies within conventional healthcare frameworks. Based in the United Kingdom, the journal not only promotes scholarly discourse but also fosters collaboration across an international community of practitioners dedicated to innovative therapeutic approaches.

ANNALS OF FAMILY MEDICINE is a leading peer-reviewed journal dedicated to advancing the field of family medicine. Published by the Annals Family Medicine, this journal plays a crucial role in disseminating high-quality research and scholarly work aimed at enhancing healthcare delivery in family settings. With an impressive Scopus ranking of #15 out of 56 in the Family Practice category and a Q1 quartile distinction, the journal is recognized for its significant contributions to the discipline. Covering a broad range of topics from 2003 to 2024, the journal encourages innovative studies, systematic reviews, and clinical practice articles that inform practitioners and researchers alike. Although not openly accessible, it provides valuable insights that are essential for anyone focused on improving the practice and pedagogy of family medicine. The journal's commitment to quality and relevance ensures its place as an indispensable resource for healthcare professionals, researchers, and students striving to make meaningful impacts in community health.

Journal of Yeungnam Medical Science, published by Yeungnam University College of Medicine and the Yeungnam University Institute of Medical Science, is an innovative open-access journal dedicated to advancing knowledge in the medical sciences. Launched in 2018, this journal encourages the dissemination of high-quality research across a broad range of medical disciplines, reinforcing its commitment to enhancing the global health community. With an E-ISSN of 2799-8010, the journal is centrally located in Daegu, South Korea, and aims to bridge the gap between research and practical application, offering a platform for researchers, professionals, and students. Although the journal is still garnering recognition, as reflected in its overall ranking within the Scopus Multidisciplinary category, it promises to play a vital role in fostering scientific exchange and collaboration. The focus on open access further ensures that groundbreaking research is readily available to a wider audience, aligning with contemporary scholarly communication trends.

Campbell Systematic Reviews, published by WILEY, is a premier open-access journal dedicated to the field of systematic reviews and evidence synthesis, with a specific emphasis on the social sciences. Since its inception in 2005, the journal has been committed to enhancing the transparency and accessibility of research findings, ensuring that high-quality evidence is available to inform policy and practice. With an impressive Q1 ranking in the Social Sciences (miscellaneous) category for 2023, and ranked #29 out of 275 in the field according to Scopus, it is a leading resource for researchers, professionals, and students interested in systematic methodologies. The journal not only provides valuable insights and rigorous assessments of existing literature but also contributes to shaping best practices in evidence-based decision-making. The open access model facilitates a broader dissemination of knowledge, making it an essential hub for anyone seeking to stay at the forefront of research in the social sciences.

Journal of Comparative Effectiveness Research is a leading academic journal dedicated to the evaluation of healthcare interventions and practices, published by Becaris Publishing. Since transitioning to a fully Open Access model in 2023, the journal has expanded its accessibility to a global audience of researchers, healthcare professionals, and policy makers. With a focus on comparative effectiveness in health policy, it has achieved a notable ranking of #132 out of 310 in the Scopus category for Medicine and Health Policy, placing it in the 57th percentile for scholarly impact. Operating from the United Kingdom, the journal encompasses research from 2012 to 2024 and firmly establishes itself in the academic landscape as a Q2 journal in the Health Policy category as of 2023. By disseminating high-quality, evidence-based research, the Journal of Comparative Effectiveness Research plays a vital role in informing clinical practice and health policy decision-making, making it an essential resource for those dedicated to improving health outcomes.

JBI Evidence Synthesis is a premier peer-reviewed journal published by Lippincott Williams & Wilkins, dedicated to advancing the field of evidence-based practice in nursing. With an impressive Q1 ranking in the 2023 category of Nursing (Miscellaneous) and holding the rank of #25 out of 139 in General Nursing according to Scopus, this journal serves as a key resource for researchers, practitioners, and students alike. Its focus on synthesizing high-quality research evidence allows for the integration of best practices into clinical settings, thereby enhancing patient care and health outcomes. Since its inception, JBI Evidence Synthesis has been committed to promoting rigorous methodologies and innovative approaches in evidence synthesis, making it an essential publication for anyone seeking to contribute to the advancement of nursing and healthcare. The journal is available in both print and online formats, ensuring wide accessibility to critical knowledge in the field.

JAMA Internal Medicine is a premier scholarly journal published by the American Medical Association, renowned for its rigorous peer-review process and commitment to advancing the field of internal medicine. With an impressive impact factor that positions it in the upper echelon of medical journals, specifically ranked at Q1 in Internal Medicine and holding a remarkable Scopus rank of #2 out of 167, the journal provides a vital platform for original research, reviews, and enlightening discussions that shape clinical practices and policies. As an accessible repository of cutting-edge findings and comprehensive analyses, JAMA Internal Medicine offers both subscription and open access options, ensuring that the latest developments in medicine are available to clinicians, researchers, and the academic community at large. With its focus spanning from 2013 to 2024 and its dedication to high-quality scholarship, the journal serves as an essential resource for those seeking to enhance their understanding of the complexities of internal medicine and improve patient care.

Reviews on Recent Clinical Trials, published by Bentham Science Publishers Ltd, is a distinguished journal in the medical and pharmacological fields, assessing the latest advancements in clinical research since its inception in 2006. With a focus on integrating multidisciplinary approaches to evaluating clinical trial methodologies, the journal caters to a diverse audience of researchers, professionals, and students keen on enhancing their knowledge and understanding of innovative therapeutic strategies and drug developments. Notably positioned in the Q3 quartile as ranked by Scopus for both 'Medicine (miscellaneous)' and 'Pharmacology', the journal illustrates a growing academic influence, evidenced by its Scopus rankings—holding a commendable 72nd percentile in general medicine and a 33rd percentile in pharmacology. While the journal is not open access, it remains committed to disseminating high-quality, peer-reviewed content that drives forward the conversation in clinical research. For those interested in staying abreast of novel findings and comprehensive reviews within the clinical trial landscape, Reviews on Recent Clinical Trials stands out as an essential resource.